Vanguard Portfolio Management
LFCR icon

Vanguard Portfolio Management’s Lifecore Biomedical LFCR Stock Holding History

Vanguard Portfolio Management’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$993K Buy
189,073
+24,513
+15% +$123K ﹤0.01% 2963
2026
Q1 		$612K Buy
+164,560
New +$1.14M ﹤0.01% 2922

Other funds holding LFCR

WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Vanguard Portfolio Management's LFCR Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Lifecore Biomedical (LFCR) stake by 15% in Q2 2026, buying an estimated $123K and bringing the position to 189,073 shares worth $993K. The position accounts for ﹤0.01% of the portfolio, ranked #2963.

Vanguard Portfolio Management first reported a position in LFCR in Q1 2026 and has held it in 2 quarters since. 98 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • Vanguard Portfolio Management held 189,073 shares of Lifecore Biomedical worth $993K as of Q2 2026.
  • Vanguard Portfolio Management bought 24,513 Lifecore Biomedical shares in Q2 2026, an estimated $123K.
  • Lifecore Biomedical made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #2963 holding.
  • Vanguard Portfolio Management first reported a position in Lifecore Biomedical in Q1 2026 and has held it in 2 quarters since.
  • 98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.